Skip to main content

Table 3 Clinical outcome in the two groups (n = 395)

From: Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease

Event SoC group (n = 188) Intervention group (n = 207) p*
End of follow-up    
 MACEs, No. (%) 146 (77.8) 116 (56.1)  < 0.001
 All-cause death, No. (%) 103 (54.8) 86 (41.6) 0.046
 Myocardial infarction, No. (%) 44 (23.4) 32 (15.5)  < 0.001
 Stroke, No. (%) 28 (14.9) 19 (9.2) 0.002
 Revascularization, No. (%) 13 (6.9) 16 (7.8) 0.33
 Major amputation, No. (%) 3 (1.6) 2 (0.9) 0.5
Follow-up at end of intervention phase    
 MACEs, No. (%) 50 (26.6) 24 (11.6) 0.002
  1. MACE Major Adverse Cardiovascular Event
  2. p-value calculated with univariable Cox shared-frailty model. Multivariable estimates are reported in the manuscript